SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-027479
Filing Date
2022-11-01
Accepted
2022-11-01 08:52:54
Documents
67
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q espr-20220930.htm   iXBRL 10-Q 1381919
2 EX-31.1 espr-ex311x09302022.htm EX-31.1 11094
3 EX-31.2 espr-ex312x09302022.htm EX-31.2 11144
4 EX-32.1 espr-ex321x09302022.htm EX-32.1 6270
  Complete submission text file 0001628280-22-027479.txt   6810180

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20220930.xsd EX-101.SCH 51159
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20220930_cal.xml EX-101.CAL 51642
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20220930_def.xml EX-101.DEF 265706
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20220930_lab.xml EX-101.LAB 629697
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20220930_pre.xml EX-101.PRE 410454
61 EXTRACTED XBRL INSTANCE DOCUMENT espr-20220930_htm.xml XML 1068599
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 221348638
SIC: 2834 Pharmaceutical Preparations